Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries

Contributed by: Business Wire

Logo

Tags

Biotechnology

Education

Health

Philanthropy

Pharmaceutical

Other Philanthropy

Training

Research

Infectious Diseases

Hospitals

Science

Takeda Pharmaceutical Company Limited

More Like This

Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Takeda Named Global Top Employer for Seventh Consecutive Year

Takeda Announces Third-Quarter FY2023 Results; On-Track Towards Full-Year Management Guidance With Strong Momentum in Growth & Launch Products

Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline

Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook

Takeda Announces New Assignments of Directors